Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.44 |
| ▸ | MAOA | P21397 | 2/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | PIM1 | P11309 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | DHFR | P00374 | 1/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | IKBKB | O14920 | 1/20 | 0.38 |
| ▸ | FLT3 | P36888 | 1/20 | 0.37 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29865394 | 1.00 | CYP2A6 (0.44) | CYP2A6TDP1CYP1A2MAOAMAOB | |
| SCHEMBL27955876 | 0.91 | CYP1A2 (0.44) | CYP2A6TDP1CYP1A2MAOAMAOB | |
| SCHEMBL365629 | 0.89 | CYP2A6 (0.55) | CYP2A6TDP1CYP1A2MAOACYP3A4 | |
| SCHEMBL29353280 | 0.89 | CYP2A6 (0.55) | CYP2A6TDP1CYP1A2MAOACYP3A4 | |
| SCHEMBL15056206 | 0.89 | CYP2A6 (0.55) | CYP2A6TDP1CYP1A2MAOACYP3A4 | |
| SCHEMBL1103650 | 0.89 | TNF (0.40) | CYP2A6TDP1CYP1A2MAOAPIM1 | |
| SCHEMBL29512215 | 0.88 | CYP2A6 (0.50) | CYP2A6TDP1CYP1A2MAOAMAOB | |
| SCHEMBL736086 | 0.88 | CYP2A6 (0.50) | CYP2A6TDP1CYP1A2MAOAMAOB | |
| SCHEMBL536536 | 0.88 | PIM1 (0.47) | CYP2A6TDP1CYP1A2PIM1CYP2C9 | |
| SCHEMBL29350427 | 0.88 | PIM1 (0.47) | CYP2A6TDP1CYP1A2PIM1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12545650-B2 | Bisanthracene derivatives having solubilizing substituent, and organic electroluminescence device using same | LG CHEM, LTD. (KR) | 2026-02-10 | — | — | US | disclosed |
| CN-114929667-B | Bihracene derivative having solubilizing substituent and organic electroluminescent device using the same | 株式会社LG化学 | 2024-05-28 | — | — | CN | disclosed |
| US-20230089555-A1 | Bisanthracene Derivatives Having Solubilizing Substituent, and Organic Electroluminescence Device Using Same | LG CHEM, LTD. (KR) | 2023-03-23 | — | — | US | disclosed |
| CN-114929667-A | Bisanthracene derivative having solubilizing substituent and organic electroluminescent device using the same | 株式会社LG化学 | 2022-08-19 | — | — | CN | disclosed |
| WO-2021141428-A1 | BISANTHRACENE DERIVATIVES HAVING SOLUBILIZING SUBSTITUENT, AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME | 주식회사 엘지화학 | 2021-07-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12545650-B2 | Bisanthracene derivatives having solubilizing substituent, and organic electroluminescence device using same | NCOR2, NCOR1, ESR2 | CYP2A6 2828/4885TDP1 2287/4885CYP1A2 585/4885 |
| US-20230089555-A1 | Bisanthracene Derivatives Having Solubilizing Substituent, and Organic Electroluminescence Device Using Same | TYR, MLLT1, XDH | CYP2A6 1635/4885TDP1 1532/4885CYP1A2 66/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.